Medios AG (0QB4.L)
EUR 11.72
(3.72%)
EUR 11.72
(3.72%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 31.37 Million EUR | -0.21% |
| 2022 | 28.96 Million EUR | 89.8% |
| 2021 | 15.26 Million EUR | 59.94% |
| 2020 | 9.54 Million EUR | -33.7% |
| 2019 | 14.39 Million EUR | 94.5% |
| 2018 | 7.39 Million EUR | 8.79% |
| 2017 | 6.8 Million EUR | 927.91% |
| 2016 | -821.48 Thousand EUR | -415.55% |
| 2015 | -159.34 Thousand EUR | -380.89% |
| 2014 | -33.13 Thousand EUR | 79.94% |
| 2013 | -165.16 Thousand EUR | 18.95% |
| 2012 | -203.78 Thousand EUR | -782.75% |
| 2011 | 29.84 Thousand EUR | -98.78% |
| 2010 | 2.43 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 6.53 Million EUR | 15.29% |
| 2024 Q2 | 6.09 Million EUR | -6.69% |
| 2023 Q4 | 5.66 Million EUR | -45.24% |
| 2023 Q3 | 10.34 Million EUR | 40.8% |
| 2023 FY | 28.9 Million EUR | -0.21% |
| 2023 Q1 | 8.02 Million EUR | 100.9% |
| 2023 Q2 | 7.34 Million EUR | -8.5% |
| 2022 Q1 | 7.84 Million EUR | 2408.24% |
| 2022 Q2 | 8.24 Million EUR | 5.06% |
| 2022 FY | 28.96 Million EUR | 89.8% |
| 2022 Q3 | 8.87 Million EUR | 7.67% |
| 2022 Q4 | 3.99 Million EUR | -54.98% |
| 2021 Q3 | 5.68 Million EUR | 207.85% |
| 2021 Q1 | 4.64 Million EUR | 51.22% |
| 2021 Q4 | -340 Thousand EUR | -105.98% |
| 2021 FY | 15.26 Million EUR | 59.94% |
| 2021 Q2 | -5.27 Million EUR | -213.62% |
| 2020 Q3 | 2.02 Million EUR | 297.95% |
| 2020 Q2 | -1.02 Million EUR | -129.78% |
| 2020 Q1 | 3.43 Million EUR | 17.12% |
| 2020 Q4 | 3.06 Million EUR | 51.41% |
| 2020 FY | 9.54 Million EUR | -33.7% |
| 2019 Q3 | 5.5 Million EUR | 71.46% |
| 2019 Q1 | 3.02 Million EUR | 28.55% |
| 2019 FY | 14.39 Million EUR | 94.5% |
| 2019 Q4 | 2.93 Million EUR | -46.7% |
| 2019 Q2 | 3.21 Million EUR | 6.39% |
| 2018 Q3 | 2.34 Million EUR | 62.44% |
| 2018 FY | 7.39 Million EUR | 8.79% |
| 2018 Q2 | 1.44 Million EUR | 0.0% |
| 2018 Q1 | 1.44 Million EUR | -1.26% |
| 2018 Q4 | 2.34 Million EUR | 0.0% |
| 2017 FY | 6.8 Million EUR | 927.91% |
| 2017 Q1 | 1.93 Million EUR | 232.86% |
| 2017 Q2 | 1.93 Million EUR | -0.0% |
| 2017 Q3 | 1.46 Million EUR | -24.25% |
| 2017 Q4 | 1.46 Million EUR | 0.0% |
| 2016 Q4 | -1.45 Million EUR | 0.0% |
| 2016 Q1 | 1.03 Million EUR | 0.0% |
| 2016 Q2 | 1.03 Million EUR | 0.0% |
| 2016 Q3 | -1.45 Million EUR | -240.66% |
| 2016 FY | -821.48 Thousand EUR | -415.55% |
| 2015 FY | -159.34 Thousand EUR | -380.89% |
| 2014 FY | -33.13 Thousand EUR | 79.94% |
| 2013 FY | -165.16 Thousand EUR | 18.95% |
| 2012 FY | -203.78 Thousand EUR | -782.75% |
| 2011 FY | 29.84 Thousand EUR | -98.78% |
| 2010 FY | 2.43 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cegedim SA | 19.98 Million EUR | -56.988% |
| Guerbet SA | 38.67 Million EUR | 18.877% |
| Nexus AG | 24.76 Million EUR | -26.67% |
| Bastide Le Confort Médical SA | 44.22 Million EUR | 29.06% |
| Revenio Group Oyj | 26.34 Million EUR | -19.087% |
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 81.674% |
| Sartorius Aktiengesellschaft | 541 Million EUR | 94.201% |
| LNA Santé SA | 62.98 Million EUR | 50.19% |
| Siemens Healthineers AG | 2.86 Billion EUR | 98.907% |
| Equasens Société anonyme | 55.2 Million EUR | 43.177% |
| Stratec SE | 22.88 Million EUR | -37.063% |